Foundation Resource Management Inc. Lowers Holdings in Sanofi (NASDAQ:SNY)

Foundation Resource Management Inc. lowered its stake in shares of Sanofi (NASDAQ:SNY) by 0.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 272,267 shares of the company’s stock after selling 1,054 shares during the period. Sanofi comprises about 2.2% of Foundation Resource Management Inc.’s investment portfolio, making the stock its 14th biggest position. Foundation Resource Management Inc.’s holdings in Sanofi were worth $13,131,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Northwest Investment Counselors LLC acquired a new position in Sanofi in the 3rd quarter worth about $29,000. Concord Wealth Partners increased its position in shares of Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after buying an additional 363 shares in the last quarter. Fortitude Family Office LLC raised its stake in shares of Sanofi by 708.6% during the 3rd quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after buying an additional 659 shares during the period. Sunbelt Securities Inc. lifted its position in shares of Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after buying an additional 313 shares in the last quarter. Finally, Versant Capital Management Inc acquired a new stake in Sanofi in the 4th quarter valued at $54,000. Institutional investors and hedge funds own 14.04% of the company’s stock.

Sanofi Price Performance

Sanofi stock opened at $48.45 on Wednesday. The company has a fifty day simple moving average of $48.53 and a 200-day simple moving average of $52.11. The firm has a market capitalization of $122.96 billion, a price-to-earnings ratio of 24.72, a PEG ratio of 1.23 and a beta of 0.57. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97.

Sanofi (NASDAQ:SNY) last released its quarterly earnings data on Friday, October 25th. The company reported $1.57 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $1.35. The company had revenue of $13.44 billion during the quarter, compared to the consensus estimate of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. Sanofi’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.55 EPS. On average, equities analysts anticipate that Sanofi will post 4.06 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. StockNews.com downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Citigroup raised shares of Sanofi to a “strong-buy” rating in a research note on Tuesday, September 17th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $57.50.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.